Amalgamated Bank Sells 4,108 Shares of Encompass Health Co. (NYSE:EHC)

Amalgamated Bank lowered its holdings in Encompass Health Co. (NYSE:EHC) by 6.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,791 shares of the company’s stock after selling 4,108 shares during the period. Amalgamated Bank owned approximately 0.06% of Encompass Health worth $5,215,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Trillium Asset Management LLC bought a new stake in shares of Encompass Health during the 1st quarter valued at $4,432,000. TD Asset Management Inc increased its position in shares of Encompass Health by 16.0% during the first quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock valued at $188,586,000 after buying an additional 314,488 shares during the period. Harbor Capital Advisors Inc. lifted its holdings in shares of Encompass Health by 275.7% in the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after buying an additional 26,270 shares in the last quarter. Epoch Investment Partners Inc. boosted its position in shares of Encompass Health by 102.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 1,399,341 shares of the company’s stock valued at $93,364,000 after acquiring an additional 709,593 shares during the period. Finally, QRG Capital Management Inc. grew its stake in Encompass Health by 85.6% during the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock valued at $1,232,000 after acquiring an additional 6,627 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on EHC shares. Stephens reissued an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. UBS Group lifted their price target on Encompass Health from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Truist Financial upped their price objective on shares of Encompass Health from $100.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. Barclays dropped their target price on shares of Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. Finally, Leerink Partners initiated coverage on shares of Encompass Health in a report on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 price target on the stock. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $100.38.

Insider Buying and Selling

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the transaction, the chief financial officer now owns 136,227 shares of the company’s stock, valued at $11,761,839.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is owned by insiders.

Encompass Health Stock Up 0.6 %

Shares of NYSE EHC opened at $92.65 on Friday. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $94.59. The company has a market cap of $9.33 billion, a price-to-earnings ratio of 25.04, a PEG ratio of 1.39 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.08. The firm’s fifty day moving average is $89.92 and its 200 day moving average is $85.12.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.10. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the previous year, the business posted $0.95 earnings per share. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, equities research analysts expect that Encompass Health Co. will post 4.18 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date is Tuesday, October 1st. This is a boost from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio (DPR) is presently 18.38%.

Encompass Health announced that its board has authorized a stock repurchase program on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 5.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.